Fig. 2From: Validation of Androgen Receptor loss as a risk factor for the development of brain metastases from ovarian cancersProgression Free Survival in relation to AR 10% (curve a, p = 0.002); Brain Progression Free Survival in relation to AR 10% (curve b, p = 0.005)Back to article page